Sebi has shared its findings about 14,720 entities that indulged in non-genuine trades through illiquid stock options with IT and the Ministry of Corporate Affairs.
Sebi plans to revise the regulations for share buybacks wherein more clarity would be provided on various aspects, including on the requirement to make public announcements.
The Reserve Bank has eased investment norms for foreign portfolio investors (FPIs) in debt, especially into individual large corporates, a move that can help attract more overseas flows.
Sebi has banned Greenbang Agro and its 10 current and former directors from the securities market for at least four years and directed them to refund the money.
Sebi imposed a total penalty of Rs 7 lakh on two entities for violating disclosure norms while dealing in the shares of Le Waterina Resort and Hotels.
BSE has asked brokers to take into consideration excess cash of clients lying with them to calculate their net obligation before levying late payment charges.
Sebi is considering capping tenure of stock exchange CEOs to maximum two terms of 5 yrs each, as part of an overhaul of regulations for ownership and governance norms for mkt infra institutions.
Markets regulator Sebi today imposed a total penalty of Rs 2 lakh on two firms for failing to obtain authentication with its online complaint redressal system within the stipulated time.
Sebi plans to put in place revised norms for recovering investors' money in cases of illegal collective investment schemes.
Fund mobilisation by Indian firms through issuance of shares to institutional investors dropped by 64 per cent to nearly Rs 1,900 crore during April 2018, in comparison to the year-ago period.
U.P. Govt cancels Purvanchal Expressway bids
Co's Rs 1,740 Cr bid for expressway section cancelled
U.P. Govt to re-invite bids for expressway project
Settles Abraxane patent dispute with Celgene Corp
Partner Apotex may sell generic of Abraxane in U.S.
Telecom Department may clear Vodafone-Idea merger today
Dr. Reddys new drug hits legal hurdle
U.S. court issues restraint order following patent litigation over Suboxone
Company remains confident in its legal positions on this patent Court order does not include a prohibition on commercial manufacturing of the product
The court has scheduled an expedited hearing of the preliminary injunction for June 28 Ruling is expected soon thereafter
Board mulls reshuffle of top management
ICICI Prudential Life Chief Bakshi may be named ICICI bank interim